GLP-1 Microdosing
Lower GLP-1 doses combined with supportive nutrients, available as a daily oral or a weekly injection. Aimed at energy, side-effect tolerance, and maintenance rather than the largest possible weight reduction.
- Open to adults with a BMI over 20
- Labs recommended, not required
- Unlimited clinician consults, async and video
- Oral and injectable formats available
shipping
doctors
doctor 24/7
- Same price at every dose. No hidden fees.
- Free expedited shipping.
- No membership fees.
- Doctor-led plans, ongoing doctor support.
Why do people explore GLP-1 microdosing therapy?
For people who want the GLP-1 mechanism without chasing the highest tolerated dose.
Gentler By Design
- Lower GLP-1 exposure
- Fewer GI effects
- Easier to tolerate
Matched To Your Goal
- Energy combinations
- Glucose support
- Sleep support
Wider Eligibility
- Open at BMI over 20
- Labs not required
- Ages 18 to 74
Care Included
- Unlimited consults
- Labs covered
- Ships every 4 weeks
A lower dose you will actually stay on.
Low-dose compounded GLP-1 paired with supportive nutrients, prescribed online by US-licensed doctors.
Standard GLP-1 protocols climb toward the highest tolerated dose, because that is where the trials found the biggest weight reduction. That works well for many people and poorly for others — some stop because of nausea, some have already reached their goal and want to hold it, and some were never candidates for a full weight-management protocol in the first place. Microdosing holds the GLP-1 dose low and pairs it with ingredients chosen against a specific goal: B12 and NAD+ for energy, inositol for glucose handling, magnesium and L-theanine for sleep.
The honest caveat matters more than the pitch. There are no randomized trials showing that these low-dose combinations reproduce the outcomes of the full-dose GLP-1 studies, and compounded preparations are not FDA-approved finished drug products. Anyone promising trial-level weight loss from a microdose is overselling it. What is real is the clinical structure around it: a US-licensed clinician who decides whether this fits your situation, unlimited consults while you are on it, and labs available at no cost. See the full Peptide12 approach to weight loss.
Complete a quick online health intake
STEP
1
Share your health profile online. A US-licensed doctor reviews your fit and decides whether peptide therapy is right for you.
Receive your prescription at your door
STEP
2
If approved, your custom prescription ships free and overnight in temperature-controlled packaging, arriving safely at your home.
Get continuous care from your doctor
STEP
3
Message your care team anytime for dose adjustments, check-ins, and ongoing support that keeps you progressing toward your goals.
Why choose Peptide12?
Patients pick us for clinical rigor, transparent pricing, and care that doesn’t disappear after checkout.
FDA-registered pharmacies
Every prescription is compounded by FDA-registered 503A/503B pharmacies. Batch testing and certificates of analysis available on request.
US-licensed doctors
MDs licensed in your state, not just an order form. Your doctor titrates dosing and answers messages directly.
Transparent pricing
One flat price per protocol. No membership fees, no insurance hassle, no surprise charges. HSA and FSA accepted. Cancel anytime.
Care that doesn’t disappear
Message your doctor through your patient portal whenever you need to. Most replies within hours, never longer than 24.
Frequently asked questions
You should not expect to. The 15–22% reductions reported in the semaglutide and tirzepatide trials came from full-dose protocols, and there is no trial evidence that low-dose combinations reproduce them. Microdosing is aimed at tolerability, energy, and maintenance. If maximum weight reduction is your goal, discuss a standard compounded protocol with your clinician instead.
The eligibility threshold is a BMI over 20 and an age between 18 and 74, which is considerably wider than the BMI 27 (or 25 with a comorbidity) threshold for standard weight-management protocols. Qualifying is still a clinical decision — your prescribing clinician reviews your history, medications, and goals before deciding whether any GLP-1 protocol is appropriate.
Labs are recommended but not required for this pathway, and they are covered at no additional cost when drawn through Quest or Labcorp. Your clinician may still ask for them before prescribing if something in your history warrants it.
That is one of the common reasons patients ask about it, and it is a reasonable conversation to have with your clinician. There is no established evidence base for microdosing as a maintenance strategy, so your clinician will set expectations, decide on a combination, and monitor how you do rather than promising a particular outcome.
Supporting Studies
- 1.Wilding JPH et al. — Once-weekly semaglutide in adults with overweight or obesity (STEP 1), NEJM 2021 — full-dose protocol, not microdosing
- 2.Jastreboff AM et al. — Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1), NEJM 2022 — full-dose protocol, not microdosing
- 3.FDA — Compounding and the FDA: questions and answers on compounded drug products